SCHEMBL1377797

SCHEMBL1377797

O=C(OCCN1CCOCC1)C1CC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.50
ALDH1A1 P00352 5/20 0.48
KMT2A Q03164 3/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 2/20 0.45
GLA P06280 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
BCHE P06276 1/20 0.44
MEN1 O00255 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
PKM P14618 1/20 0.43
CYP2C19 P33261 1/20 0.43
PRCP P42785 1/20 0.43
TMEM97 Q5BJF2 1/20 0.43
SIGMAR1 Q99720 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL501793 0.93 ATM (0.48) ATMALDH1A1KMT2ALMNAGAA
SCHEMBL20431 0.92 ATM (0.47) ATMALDH1A1KMT2ALMNAGAA
SCHEMBL18023845 0.91 ATM (0.46) ATMALDH1A1KMT2ALMNAGAA
SCHEMBL22878181 0.89 ATM (0.45) ATMALDH1A1KMT2ALMNAGAA
Hydrochloric Acid SCHEMBL17271473 0.88 ALDH1A1 (0.45) ATMALDH1A1KMT2ALMNAGAA
SCHEMBL17286078 0.88 LMNA (0.44) ATMALDH1A1KMT2ALMNAGAA
SCHEMBL17285898 0.88 SMN1; SMN2 (0.45) ATMALDH1A1KMT2ALMNAGAA
SCHEMBL22878194 0.87 ATM (0.43) ATMALDH1A1KMT2ALMNAGAA
SCHEMBL17284696 0.87 ATM (0.43) ATMALDH1A1KMT2ALMNAGAA
SCHEMBL17282078 0.85 ATM (0.42) ATMALDH1A1KMT2ALMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1868982-B1 COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE UNIV ALBERTA (CA) 2015-04-29 EP claimed
JP-4764888-B2 2011-09-07 JP claimed
US-20090258835-A1 COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE THE GOVERNORS OF THE UNIVERSITY OF ALBERTA TEC EDMONTON (CA) 2009-10-15 US claimed
US-7524885-B2 Compounds that stimulate glucose utilization and methods of use THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2009-04-28 US claimed
EP-1868982-A2 COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE The Governors of the University of Alberta (CA) 2007-12-26 EP claimed
WO-2006117686-A2 COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2006-11-09 WO claimed
US-20050182133-A1 Compounds that stimulate glucose utilization and methods of use UNIVERSITY OF ALBERTA (CA) 2005-08-18 US claimed
EP-1868982-B1 COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE UNIV ALBERTA (CA) 2015-04-29 EP disclosed
US-8202901-B2 Compounds that stimulate glucose utilization and methods of use THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2012-06-19 US disclosed
US-8202901-B2 Compounds that stimulate glucose utilization and methods of use THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2012-06-19 US disclosed
US-20090258835-A1 COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE THE GOVERNORS OF THE UNIVERSITY OF ALBERTA TEC EDMONTON (CA) 2009-10-15 US disclosed
US-20090258835-A1 COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE THE GOVERNORS OF THE UNIVERSITY OF ALBERTA TEC EDMONTON (CA) 2009-10-15 US disclosed
US-7524885-B2 Compounds that stimulate glucose utilization and methods of use THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2009-04-28 US disclosed
US-7524885-B2 Compounds that stimulate glucose utilization and methods of use THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2009-04-28 US disclosed
US-7524885-B2 Compounds that stimulate glucose utilization and methods of use THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2009-04-28 US disclosed
US-20050182133-A1 Compounds that stimulate glucose utilization and methods of use UNIVERSITY OF ALBERTA (CA) 2005-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182133-A1 Compounds that stimulate glucose utilization and methods of use GPR119, SLC2A4, SLC2A1 ATM 2935/4885ALDH1A1 1918/4885KMT2A 4588/4885
US-20090258835-A1 COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE GPR119, SLC2A4, SLC2A1 ATM 2935/4885ALDH1A1 1918/4885KMT2A 4588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.